Literature DB >> 30224409

New therapies to relieve pain: The search for more efficient and safer alternatives to opioid pain killers.

Philip Hunter1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30224409      PMCID: PMC6172456          DOI: 10.15252/embr.201846925

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  8 in total

1.  Long-lasting antinociceptive effects of green light in acute and chronic pain in rats.

Authors:  Mohab M Ibrahim; Amol Patwardhan; Kerry B Gilbraith; Aubin Moutal; Xiaofang Yang; Lindsey A Chew; Tally Largent-Milnes; T Philip Malan; Todd W Vanderah; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2017-02       Impact factor: 6.961

2.  Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Authors:  Susruta Majumdar; Steven Grinnell; Valerie Le Rouzic; Maxim Burgman; Lisa Polikar; Michael Ansonoff; John Pintar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

3.  A nontoxic pain killer designed by modeling of pathological receptor conformations.

Authors:  V Spahn; G Del Vecchio; D Labuz; A Rodriguez-Gaztelumendi; N Massaly; J Temp; V Durmaz; P Sabri; M Reidelbach; H Machelska; M Weber; C Stein
Journal:  Science       Date:  2017-03-03       Impact factor: 47.728

4.  Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.

Authors:  Kenji Hanamura; Halley R Washburn; Sean I Sheffler-Collins; Nan L Xia; Nathan Henderson; Dipti V Tillu; Shayne Hassler; Daniel S Spellman; Guoan Zhang; Thomas A Neubert; Theodore J Price; Matthew B Dalva
Journal:  PLoS Biol       Date:  2017-07-18       Impact factor: 8.029

5.  Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials.

Authors:  Pascal Tétreault; Ali Mansour; Etienne Vachon-Presseau; Thomas J Schnitzer; A Vania Apkarian; Marwan N Baliki
Journal:  PLoS Biol       Date:  2016-10-27       Impact factor: 8.029

6.  Trypsin-protease activated receptor-2 signaling contributes to pancreatic cancer pain.

Authors:  Jiao Zhu; Xue-Rong Miao; Kun-Ming Tao; Hai Zhu; Zhi-Yun Liu; Da-Wei Yu; Qian-Bo Chen; Hai-Bo Qiu; Zhi-Jie Lu
Journal:  Oncotarget       Date:  2017-06-27

Review 7.  Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases.

Authors:  Sun H Park; Matthew R Eber; D Brooke Widner; Yusuke Shiozawa
Journal:  Cancers (Basel)       Date:  2018-05-10       Impact factor: 6.639

8.  Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.

Authors:  Viola Spahn; Giovanna Del Vecchio; Antonio Rodriguez-Gaztelumendi; Julia Temp; Dominika Labuz; Michael Kloner; Marco Reidelbach; Halina Machelska; Marcus Weber; Christoph Stein
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

  8 in total
  1 in total

Review 1.  Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.

Authors:  Halina Machelska; Melih Ö Celik
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.